Video: LAPAROSCOPIC CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAPERITONEAL CHEMOPERFUSION IN GASTRIC CANCER

Abstract





Peritoneal metastasis from gastric cancer represents advanced disease with poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemoperfusion (HIPEC) has shown survival benefit in some malignancies, but its role in the treatment of gastric cancer peritoneal metastasis is not completely elucidated. CRS-HIPEC at the time of potentially curative gastrectomy seems to add survival benefit, especially in patients with positive cytology.


Laparoscopic CRS-HIPEC (L-CRS-HIPEC) has been investigated as a less invasive treatment option in patients with gastric cancer with limited peritoneal carcinomatosis or positive peritoneal cytology.


We aim to present a case of a 61-year-old woman with a gastric adenocarcinoma from the lesser curvature, with a positive cytology for tumor cells. The patient initiated chemotherapy with FOLFOX and the re-staging CT scan showed no sign of distant metastasis.





Downloads

Download data is not yet available.
Published
2023-06-23
How to Cite
NOGUEIRO, Jorge et al. Video: LAPAROSCOPIC CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAPERITONEAL CHEMOPERFUSION IN GASTRIC CANCER. Revista Portuguesa de Cirurgia, [S.l.], n. 55, p. 67-69, june 2023. ISSN 2183-1165. Available at: <https://revista.spcir.com/index.php/spcir/article/view/987>. Date accessed: 30 may 2024. doi: https://doi.org/10.34635/rpc.987.
Section
Videos